BIS Research - Emerging Technology Market Intelligence

Regenerative Medicines Taking Over the Traditional Medicines to Provide Better Treatment

Mar 12, 2018 5:34:20 AM / by BIS Research posted in Global Stem Cells Market, Global Tissue Engineering Market, regenerative medicine market size, Global Gene Therapy Market, growth of regenerative medicine, Healthcare & Medical, Global Regenerative Medicines Market, regenerative medicine industry report, regenerative medicine market, regenerative medicine market growth, regenerative medicine market report, regenerative medicine market trends, stem cell therapy market

0 Comments

Regenerative Medicines represent the new paradigm in human health, with the potential to resolve unmet medical needs by addressing the underlying cause of disease. This rapidly evolving, interdisciplinary field in healthcare is transforming the practice of medicine in the medical world. According to the market intelligence report of BIS Healthcare titled, ‘Global Regenerative Medicines Market- Analysis and Forecast’, the market is expected to reach $50.55 billion by 2025 from $17.03 billion in 2016. This significant growth can be attributed to the rising awareness about the regenerative medicines, technological advancements, and better efficacy as well as safety provided by such medicines. Furthermore, the regenerative medicines involve three types of therapies, known as gene therapy, cell therapy, and tissue engineering therapy. Presently, the tissue-engineered therapy product segment dominates the market with 63% of share and $10.7 billion revenue generated from more than 200 companies, across the globe. Moreover, it is expected that the gene therapy is going to lead the market during the forecast period, owing to escalating prevalence of chronic diseases, increasing geriatric population, and improved safety and outcomes, provided by the gene therapy products.

Read More

    Subscribe to Email Updates

    Lists by Topic

    see all

    Have Questions? Schedule a Call